These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10223409)

  • 1. The 301 to 314 amino acid residue of beta-tubulin is not a target epitope for serum IgM antibodies in chronic inflammatory demyelinating polyneuropathy.
    Tagawa Y; Yuki N; Hirata K
    J Neurol Sci; 1999 Feb; 163(1):44-6. PubMed ID: 10223409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum IgM monoclonal autoantibody binding to the 301 to 314 amino acid epitope of beta-tubulin: clinical association with slowly progressive demyelinating polyneuropathy.
    Connolly AM; Pestronk A; Mehta S; Yee WC; Green BJ; Fellin C; Olney RK; Miller RG; Devor WN
    Neurology; 1997 Jan; 48(1):243-8. PubMed ID: 9008525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Yuki N; Tagawa Y; Handa S
    J Neuroimmunol; 1996 Oct; 70(1):1-6. PubMed ID: 8862128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-titer selective serum anti-beta-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy.
    Connolly AM; Pestronk A; Trotter JL; Feldman EL; Cornblath DR; Olney RK
    Neurology; 1993 Mar; 43(3 Pt 1):557-62. PubMed ID: 8451001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tubulin autoantibodies in acquired demyelinating polyneuropathies.
    Connolly AM; Pestronk A
    J Infect Dis; 1997 Dec; 176 Suppl 2():S157-9. PubMed ID: 9396702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-alpha- and beta-tubulin IgM antibodies in dysimmune neuropathies.
    Manfredini E; Nobile-Orazio E; Allaria S; Scarlato G
    J Neurol Sci; 1995 Nov; 133(1-2):79-84. PubMed ID: 8583236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis].
    Irie S; Saito T; Kanazawa N; Ito H; Kowa H
    Rinsho Shinkeigaku; 1994 May; 34(5):454-60. PubMed ID: 7924057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
    J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-titer immunoglobulin M antibody to nerve-specific class III beta-tubulin in the serum of a patient with sensory demyelinating polyneuropathy.
    Stubbs EB; Fisher MA; Wilson JR; Siegel GJ
    Muscle Nerve; 1996 Dec; 19(12):1638-9. PubMed ID: 8941286
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum antibodies to heparan sulfate glycosaminoglycans in Guillain-Barré syndrome and other demyelinating polyneuropathies.
    Pestronk A; Choksi R; Yee WC; Kornberg AJ; Lopate G; Trotter J
    J Neuroimmunol; 1998 Nov; 91(1-2):204-9. PubMed ID: 9846837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed appearance of anti-myelin-associated glycoprotein antibodies in a patient with chronic demyelinating polyneuropathy.
    Valldeoriola F; Graus F; Steck AJ; Muñoz E; de la Fuente M; Gallart T; Ribalta T; Bombí JA; Tolosa E
    Ann Neurol; 1993 Sep; 34(3):394-6. PubMed ID: 7689821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy.
    Meléndez-Vásquez C; Redford J; Choudhary PP; Gray IA; Maitland P; Gregson NA; Smith KJ; Hughes RA
    J Neuroimmunol; 1997 Mar; 73(1-2):124-34. PubMed ID: 9058768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-neuroblastoma cell line antibodies in inflammatory demyelinating polyneuropathy: inhibition in vitro and in vivo by IV immunoglobulin.
    van Doorn PA; Brand A; Vermeulen M
    Neurology; 1988 Oct; 38(10):1592-5. PubMed ID: 2843794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-beta-tubulin antibodies have no diagnostic value in patients with chronic inflammatory demyelinating polyneuropathy.
    van Schaik IN; Vermeulen M; van Doorn PA; Brand A
    J Neurol; 1995 Sep; 242(9):599-603. PubMed ID: 8551323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates.
    Pestronk A; Choksi R
    Neurology; 1997 Nov; 49(5):1289-92. PubMed ID: 9371910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-GD1a ganglioside antibodies in peripheral motor syndromes.
    Carpo M; Nobile-Orazio E; Meucci N; Gamba M; Barbieri S; Allaria S; Scarlato G
    Ann Neurol; 1996 Apr; 39(4):539-43. PubMed ID: 8619533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibodies to GM1 ganglioside in motor neuron disease--in comparison with demyelinating neuropathy].
    Irie S; Saito T; Ogino M; Ito H; Kowa H
    Rinsho Shinkeigaku; 1992 Oct; 32(10):1075-80. PubMed ID: 1297550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofascin as a target for autoantibodies in peripheral neuropathies.
    Ng JK; Malotka J; Kawakami N; Derfuss T; Khademi M; Olsson T; Linington C; Odaka M; Tackenberg B; Prüss H; Schwab JM; Harms L; Harms H; Sommer C; Rasband MN; Eshed-Eisenbach Y; Peles E; Hohlfeld R; Yuki N; Dornmair K; Meinl E
    Neurology; 2012 Dec; 79(23):2241-8. PubMed ID: 23100406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.